Literature DB >> 8866939

The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety.

M Jessa1, M Nazar, A Bidzinski, A Plaznik.   

Abstract

The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in the Vogel conflict test, and in the open field test of neophobia, were studied in rats. The drugs were given at doses active acutely, for 5 days, the last dose was administered 30 or 60 min prior to testing. It appeared that diazepam and MK-801 treated animals showed clear-cut signs of behavioral tolerance and motor sensitization, respectively. CGP 37849 was characterized by the best pharmacological profile, in that on repeated administration the drug not only retained its anxiolytic-like potency in the Vogel test, but even enhanced rat exploratory behavior in a new environment, independently of changes in animal motor activity. Repeated injections of the examined agents did not cause any significant modifications in monoamine levels and their turnover rates, in the striatum and limbic forebrain. It is concluded that the new class of competitive NMDA receptor antagonists, exemplified by CGP 37849, is the most promising candidate for clinical trials in anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866939     DOI: 10.1016/0924-977x(95)00068-z

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  10 in total

1.  Repeated maternal glucocorticoid treatment affects activity and hippocampal NMDA receptor expression in juvenile guinea pigs.

Authors:  Dawn Owen; Stephen G Matthews
Journal:  J Physiol       Date:  2006-10-26       Impact factor: 5.182

2.  An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice.

Authors:  Harish G Bagewadi; Afzal Khan Ak; Rekha M Shivaramegowda
Journal:  J Clin Diagn Res       Date:  2015-08-01

3.  Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.

Authors:  E Tatarczyńska; A Klodzińska; E Chojnacka-Wójcik; A Palucha; F Gasparini; R Kuhn; A Pilc
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

4.  Benzodiazepine-GABAA receptor complex ligands in two models of anxiety.

Authors:  M Nazar; M Jessa; A Płaźnik
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 5.  Modeling anxiety using adult zebrafish: a conceptual review.

Authors:  Adam Stewart; Siddharth Gaikwad; Evan Kyzar; Jeremy Green; Andrew Roth; Allan V Kalueff
Journal:  Neuropharmacology       Date:  2011-08-09       Impact factor: 5.250

6.  Inter-individual differences in laboratory rats as revealed by three behavioural tasks.

Authors:  Veronika Rudolfová; Tomáš Petrásek; Eliška Antošová; Daniel Frynta; Eva Landová; Karel Valeš; Tereza Nekovářová
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

Review 7.  Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion.

Authors:  Christopher Barkus; Stephen B McHugh; Rolf Sprengel; Peter H Seeburg; J Nicholas P Rawlins; David M Bannerman
Journal:  Eur J Pharmacol       Date:  2009-10-15       Impact factor: 4.432

8.  Differential effects of ethanol and midazolam upon the devaluation of an aversive memory in infant rats.

Authors:  Ricardo Marcos Pautassi; Michael Nizhnikov; Juan Carlos Molina; Stephen L Boehm; Norman Spear
Journal:  Alcohol       Date:  2007-09       Impact factor: 2.405

9.  Inhibition of the NMDA receptor/Nitric Oxide pathway in the dorsolateral periaqueductal gray causes anxiolytic-like effects in rats submitted to the Vogel conflict test.

Authors:  Lucas Lm Tonetto; Ana L Terzian; Elaine A Del Bel; Francisco S Guimarães; Leonardo Bm Resstel
Journal:  Behav Brain Funct       Date:  2009-09-23       Impact factor: 3.759

10.  Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions.

Authors:  Waseem Hassan; Carlos Eduardo Barroso Silva; Imdad Ullah Mohammadzai; Joao Batista Teixeira da Rocha; Landeira-Fernandez J
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.